Feature

Commentary: NHS patients should have a choice of drug for wet age-related macular degeneration, despite pressure from pharma

BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5013 (Published 01 November 2017) Cite this as: BMJ 2017;359:j5013